Jason Foss is an accomplished professional with extensive experience in corporate development and finance within the life sciences and healthcare sectors. Currently serving as Head of Corporate Development at Bora Pharmaceuticals and Managing Director at Dogwood Trail Advisors since April and March 2023, respectively, Jason Foss specializes in corporate finance, strategy, and M&A advisory services. Previous roles include Managing Director at CG Results Healthcare, where advisory services were provided to corporate and private equity clients from July 2014 to March 2023, and Director at Illumina Capital, focusing on biopharma and healthcare consulting from 2009 to 2018. Early career positions include roles at Gryphon Emerging Markets, Citigroup, Bear Stearns, UBS Investment Bank, and Morgan Stanley, contributing to extensive expertise in healthcare investment banking. Jason Foss holds an MBA in Finance and Accounting from The University of Chicago Booth School of Business and a BA in Psychology and Russian Area Studies from Georgetown University.